Contact Us
join our enewsletter  |   translate
Donate
Print Page    A A

Losartan

Status
Phase 2
Condition
COVID-19
Intervention Type
Oral Drug
Funder Type
Organization | University

Drug Details

Losartan is an angiotensin II receptor antagonists. It keeps blood vessels from narrowing, which lowers blood pressure and improves blood flow. 

Study Details

There are multiple studies involving losartan and its effect on COVID-19 prevention or progression. Click the icon below to learn about the various studies.

Find a Clinical Trial

 

footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >


The Pulmonary Fibrosis Foundation rates among top charities in the U.S. The PFF has a four-star rating from Charity Navigator and is a Better Business Bureau accredited charity. The Foundation has met all of the requirements of the National Health Council Standards of Excellence Certification Program®.

Charity Navigator 4 star     better business bureau logo      NHCSEP_PFF      Giving Star

PRIVACY POLICY    TERMS OF USE

© 2019 Pulmonary Fibrosis Foundation   |   230 East Ohio Street, Suite 500, Chicago, Illinois 60611

p. 888.733.6741   |   f. 866.587.9158   |   info@pulmonaryfibrosis.org
Join Our Monthly eNewsletter

PRIVACY POLICY    TERMS OF USE

© 2019 Pulmonary Fibrosis Foundation   |   230 East Ohio Street, Suite 500, Chicago, Illinois 60611

p. 888.733.6741   |   f. 866.587.9158   |   info@pulmonaryfibrosis.org

Join Our Monthly eNewsletter
Subscribe to receive the most current news and updates from the Pulmonary Fibrosis Foundation.